Evidence map›Paper›PMID 35351808›Full record

SynthesisRMD open2022

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Maud Wieczorek, James Martin Gwinnutt, Maxime Ransay-Colle, Andra Balanescu, Heike Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli, Savia de Souza, Annette de Thurah, Thomas Ernst Dorner and 10 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in RMD open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 12 countries.

Maud Wieczorek *Centre on Aging and Mobility, University Hospital Zurich, Zurich City Hospital - Waid and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-4528-9923
James Martin Gwinnutt *Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.ORCID 0000-0002-1435-8797
Maxime Ransay-Colle *EA4360 Apemac, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Andra BalanescuDepartment of Internal Medicine and Rheumatology, "Sf. Maria" Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Heike Bischoff-FerrariCentre on Aging and Mobility, University Hospital Zurich, Zurich City Hospital - Waid and University of Zurich, Zurich, Switzerland.
Annelies BoonenDepartment of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0003-0682-9533
Giulio CavalliUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.ORCID 0000-0001-8728-3004
Savia de SouzaCentre for Rheumatic Diseases, King's College London, London, UK.
Annette de ThurahDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-0103-4328
Thomas Ernst DornerCentre for Public Health, Department of Social and Preventive Medicine, Medical University of Vienna, Vienna, Austria.
Rikke Helene MoeNational Advisory Unit for Rehabilitation in Rheumatology, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.ORCID 0000-0001-7601-5346
Polina PutrikDepartment of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
Javier Rodríguez-CarrioArea of Immunology, Department of Functional Biology, Universidad de Oviedo, Oviedo, Spain.ORCID 0000-0002-0011-5102
Lucía Silva-FernándezRheumatology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Tanja A StammSection for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-3073-7284
Karen Walker-BoneMRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton, Southampton, UK.
Joep WellingNVLE Dutch Patient Organization for Systemic Autoimmune Diseases, Utrecht, The Netherlands.
Mirjana Zlatkovic-SvendaInstitute of Rheumatology, University of Belgrade School of Medicine, Belgrade, Serbia.ORCID 0000-0002-7123-140X
Suzanne Mm Verstappen *Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK suzanne.verstappen@manchester.ac.uk.
Francis Guillemin *EA4360 Apemac, University of Lorraine, Vandoeuvre-lès-Nancy, France.ORCID 0000-0002-9860-7024
Maastricht University · NLUniversity of Zurich · CHAarhus University · DKArthritis UK · GBCarol Davila University of Medicine and Pharmacy · RODiakonhjemmet Hospital · NOHospital Universitario Son Espases · ESInserm · FRInterdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est · FRKarl Landsteiner Society · ATKing's College London · GBManchester Academic Health Science Centre · GBStatistics Austria · ATUniversidad de Oviedo · ESUniversity of East Sarajevo · BAUniversity of Manchester · GBVita-Salute San Raffaele University · IT

Funding

Department of HealthMedical Research Council MC_PC_15015Medical Research Council MC_PC_21002Versus Arthritis 20380Versus Arthritis 20385
6 · The paper itself

Abstract

backgroundA EULAR taskforce was convened to develop recommendations for lifestyle behaviours in rheumatic and musculoskeletal diseases (RMDs). The aim of this paper was to review the literature on the relationship between smoking and alcohol consumption with regard to RMD-specific outcomes.

methodsTwo systematic reviews were conducted to identify systematic reviews and meta-analyses, published between 2013 and 2018, related to smoking and alcohol consumption in seven RMDs: osteoarthritis (OA), rheumatoid arthritis (RA), systemic lupus erythematosus, axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), systemic sclerosis (SSc) and gout. Two additional systematic reviews were performed to identify original longitudinal studies on smoking and alcohol consumption and disease-specific outcomes.

resultsNine reviews and 65 original studies on smoking as well as two reviews and 14 original studies on alcohol consumption met the inclusion criteria. While most studies were moderate/poor quality, smoking was significantly associated with poorer outcomes: cardiovascular comorbidity; poorer response to RA treatment; higher disease activity and severity in early RA; axSpA radiographic progression. Results were heterogeneous for OA while there was limited evidence for PsA, SSc and gout. Available studies on alcohol mainly focused on RA, reporting a positive association between alcohol intake and radiographic progression. Five studies assessed alcohol consumption in gout, reporting a significant association between the number and type of alcoholic beverages and the occurrence of flares.

conclusionCurrent literature supports that smoking has a negative impact on several RMD-specific outcomes and that moderate or high alcohol consumption is associated with increased risk of flares in RA and gout.

Indexed as

Arthritis, RheumatoidMusculoskeletal DiseasesAlcohol DrinkingHumansLife StyleMeta-Analysis as TopicSmokingSystematic Reviews as TopicEpidemiologyPatient Reported Outcome MeasuresSmoking

Identifiers

PMID35351808
PMCPMC8966569
OpenAlexW4221009769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.